Evidence map›Paper›PMID 38147840›Full record

ArticleJournal of Korean medical science2023

Significant Gap Between Guidelines and Practice in the Management of LDL Cholesterol: Insight From the Survey of the Korean Society of Myocardial Infarction.

Sang Yeub Lee, Kyung Hoon Cho, Jang Hoon Lee, Young Joon Hong, Jin Yong Hwang, Myung Ho Jeong, Weon Kim

Open access · goldAbstract read
In one paragraph

Article in Journal of Korean medical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Sang Yeub LeeDivision of Cardiology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.ORCID https://orcid.org/0000-0003-1386-349X
Kyung Hoon ChoDepartment of Cardiology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, Korea.ORCID https://orcid.org/0000-0002-0377-6352
Jang Hoon LeeDepartment of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea.ORCID https://orcid.org/0000-0002-7101-0236
Young Joon HongDepartment of Cardiology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, Korea.ORCID https://orcid.org/0000-0003-0192-8161
Jin Yong HwangDepartment of Internal Medicine, College of Medicine, Gyeongsang National University and Hospital, Jinju, Korea.ORCID https://orcid.org/0000-0002-6632-7239
Myung Ho JeongDepartment of Cardiology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, Korea.ORCID https://orcid.org/0000-0003-2424-810X
Weon KimDepartment of Cardiovascular Medicine, Kyung Hee University Hospital, Seoul, Korea. mylovekw@hanmail.net.ORCID https://orcid.org/0000-0003-1264-9870
Chonnam National University Hospital · KRGyeongsang National University Hospital · KRKyung Hee University · KRKyungpook National University Hospital · KRSungae Hospital · KR

Funding

National Evidence-based Healthcare Collaborating Agency HC21C0077
6 · The paper itself

Abstract

The Guidelines of the 2019 European Society of Cardiology (ESC) and the 5th Society of Lipid and Atherosclerosis (KSoLA) for the Management of Dyslipidemia advocate a more intensive lipid-lowering strategy. However, there is a lack of evidence regarding the current status of lipid management in Korean patients in real-world practice. The Korean Society of Myocardial Infarction conducted a survey among its members of the Korean Society of Cardiology on the new lipid guidelines. Although most participants were aware of the changes in the ESC and the KSoLA guidelines, more than half of them did not agree with lowering the low-density lipoprotein cholesterol levels to < 55 mg/dL, because its safety and efficacy have not yet been proven in Koreans. A substantial disparity exists between lipid management guidelines and current clinical practices, highlighting the necessity for clinical research that specifically targets East Asians and Koreans to bridge this gap.

Indexed as

AtherosclerosisDyslipidemiasHydroxymethylglutaryl-CoA Reductase InhibitorsMyocardial InfarctionCholesterol, LDLHumansRepublic of KoreaCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsCholesterolDyslipidemiasLow-density Lipoprotein CholesterolMyocardial Infarction

Identifiers

PMID38147840
PMCPMC10752743
OpenAlexW4389639836

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.